Assessment of Serum Phosphate in Patients with Acute Respiratory Distress Syndrome on Mechanical Ventilation and Its Effect on Disease Severity and Mortality

Authors

  • Zahraa Emad Abbas Diploma in Respiratory Medicine, Babylon Health Directorate, Babylon Province, Iraq.
  • Jehan Ali Hashim Ibrahim Diploma in Respiratory Medicine, Babylon Health Directorate, Babylon Province, Iraq

DOI:

https://doi.org/10.48165/sajssh.2024.6404

Keywords:

Acute Respiratory Distress Syndrome (ARDS), Hypophosphatemia, Serum Phosphate, Mortality and Prognostic Biomarker

Abstract

Background: Acute respiratory distress syndrome (ARDS) is a severe form of respiratory  failure, life-threatening condition, characterized by rapid onset of widespread inflammation in  the lungs and severe hypoxemia with significant impact on the morbidity and mortality of  critical care patients who have a high prevalence of hypophosphatemia because of the  presence of multiple causal factors . Identification of prognostic biomarker for ARDS as  serum phosphate may aid in improving survival. Objective of the study: Evaluate role of  hypophosphatemia in disease severity and mortality. Method: prospective study was  conducted from 1st of October 2018 to1sof June 2019, on Fifty subjects with ARDS on  mechanical ventilation in the intensive care units (ICUs) of medical city hospitals in  Baghdad, variable ages, variable risk factors. Serum phosphate level measured for all study  sample. Results: Fifty patients with ARDS, 26%mild 50%moderate 24%severe severity, 56%  female versus 44% male. The mean age for ARDS was 49.56 ± 20.31 years, aged >50 years  (48%). Pneumonia (28%) was common risk factor. 30% hypophosphatemia versus 6%  hyperphosphatemia. 60% of study patients were died. There was no significant association  between severity of ARDS and S. Phosphate level (P ≥ 0.05). There was significant association  between prevalence of mortality and S. Phosphate level (P ≤ 0.05). The cut point of S.  Phosphate was 3.1 mg/dL, S. Phosphate < 3.1 mg/dL is predicator for risk of mortality as a  large significant area under the curve (AUC= 71.5%) indicating significant association between  S. Phosphate level and risk of mortality. S. Phosphate was 80% sensitive, 60% specific, and  72% accurate as a predictor for risk of mortality. Conclusion: Patients with ARDS have low  serum phosphate level tend to increase mortality rate. Evaluation the serum phosphate  concentration carefully and early detection of hypophosphatemia in patients with ARDS and  correcting it to within normal range if possible. 

 

References

Adrion, C., Weiss, B., Paul, N., Berger, E., Busse, R., Marschall, U., Caumanns, J., Rosseau, S., Mansmann, U., Spies, C., & ERIC study group. (2020). Enhanced Recovery after Intensive Care (ERIC): Study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes. BMJ Open, 10(9), e036096. https://doi.org/10.1136/bmjopen-2019-036096

Arend, W. P., Armitage, J. O., Clemmous, D. R., et al. (Eds.). (2012). Goldman’s Cecil Medicine (24th ed., p. 755). Philadelphia: Elsevier Saunders.

Brunelli, S. M., & Goldfarb, S. (2007). Hypophosphatemia: Clinical consequences and management. Journal of the American Society of Nephrology, 18(7), 1999–2003. https://doi.org/10.1681/ASN.2007020143

Cehovic, G. A., Hatton, K. W., & Fahy, B. G. (2009). Adult respiratory distress syndrome. International Anesthesiology Clinics, 47(1), 83–95. https://doi.org/10.1097/AIA.0b013e3181958a7d

Cohen, J., Kogan, A., Sahar, G., Lev, S., Vidne, B., & Singer, P. (2004). Hypophosphatemia following open heart surgery: Incidence and consequences. European Journal of Cardiothoracic Surgery, 26, 306–310.

Cutts, S., Talboys, R., Paspula, C., Prempeh, E. M., Fanous, R., & Ail, D. (2017). Adult respiratory distress syndrome. Annals of the Royal College of Surgeons of England, 99(1), 12–16. https://doi.org/10.1308/rcsbull.2017.12

Doig, G. S., Bellomo, R., Simson, F., Hegarty, C., Egi, M., Sweetman, E. A., et al. (2009). Hypophosphatemia occurs early in ICU stay and is associated with increased duration of mechanical ventilation and ICU and hospital stay. American Journal of Respiratory and Critical Care Medicine, 179, 23–29.

Estenssoro, E., Dubin, A., Laffaire, E., et al. (2002). Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Critical Care Medicine, 30(11), 2450–2456. https://doi.org/10.1097/00003246-200211000-00008

Hoffmann, M., Zemlin, A. E., Meyer, W. P., & Erasmus, R. T. (2008). Hypophosphataemia at a large academic hospital in South Africa. Journal of Clinical Pathology, 61, 1104–1107.

Huang, C. C., Fu, J. Y., Hu, H. C., et al. (2008). Prediction of fluid responsiveness in acute respiratory distress syndrome patients ventilated with low tidal volume and high PEEP. Critical Care Medicine, 36(10), 2810–2816. https://doi.org/10.1097/CCM.0b013e318186b74e

Kumpf, O., Braun, J. P., Brinkmann, A., et al. (2017). Quality indicators in intensive care medicine for Germany - third edition 2017. German Medical Science: GMS e-journal, 15, Doc10. https://doi.org/10.3205/000251

Lee, W. L., & Slutsky, A. S. (2016). Acute hypoxemic respiratory failure and ARDS. In Broaddus, V. C., Mason, R. J., Ernst, J. D., et al. (Eds.), Murray & Nadel’s Textbook of Respiratory Medicine (6th ed., p. 1750). Philadelphia: Elsevier Saunders.

Levy, B. D., & Choi, A. M. (2018). Acute respiratory distress syndrome. In Jameson, J. L., Fauci, A. S., Kasper, D. L., et al. (Eds.), Harrison’s Principles of Internal Medicine (20th ed., pp. 2030–2034). New York: McGraw-Hill.

Li, J. B., Zhang, L., Zhu, K. M., & Deng, X. M. (2007). Retrospective analysis on acute respiratory distress syndrome in ICU. Chinese Journal of Traumatology, 10(4), 200–205.

Obaid, A. F., Shlash, A. M. J., Abdulrasol, Z. A., & Lafta, M. A. (2022). The consequences of COVID-19 and its vaccine on pregnant and lactating mothers. The Egyptian Journal of Immunology, 29(4), 58–74. http://dx.doi.org/10.55133/eji.290406

Sakhawey, A., Alawady, S., & Razek, A. A. (2015). Effect of phosphate level on the outcome in the intensive care unit. Journal of American Science, 11, 82–88.

Shor, R., Halabe, A., Rishver, S., et al. (2006). Severe hypophosphatemia in sepsis as a mortality predictor. Annals of Clinical and Laboratory Science, 36, 67–72.

Talib, A., Al Sa'ady, A., Abdulrasol, Z., Obaid, A., Abdul-Amir, H., Alhindy, M., Al-Mumin, A., & Makki, H. (2022). Prevalence of adverse effects from COVID-19 vaccine among Iraqi adults: A retrospective cross-sectional study. Journal of Emergency Medicine, Trauma and Acute Care, 3, 1–9. https://doi.org/10.5339/jemtac.2022.ismc.6

Villar, J., Pérez-Méndez, L., López, J., et al. (2007). An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 176(8), 795–804. https://doi.org/10.1164/rccm.200610-1534OC

Vistisen, S. T., & Larsson, A. (2009). Prediction of fluid responsiveness in ARDS patients ventilated with low tidal volume and high PEEP. Critical Care Medicine, 37(6), 2146. https://doi.org/10.1097/CCM.0b013e3181a0974e

Downloads

Published

2025-08-02

How to Cite

Emad Abbas, Z., & Ali Hashim Ibrahim, J. (2025). Assessment of Serum Phosphate in Patients with Acute Respiratory Distress Syndrome on Mechanical Ventilation and Its Effect on Disease Severity and Mortality. South Asian Journal of Social Sciences and Humanities, 6(4), 63-74. https://doi.org/10.48165/sajssh.2024.6404